Subscribe To
These 3 stocks just declared dividend raises
Big names in the food and beverage, industrial, and pharmaceutical sectors are lifting their payouts....
February 18, 2022, 8:30 am
These 3 stocks just declared dividend raises
Big names in the food and beverage, industrial, and pharmaceutical sectors are lifting their payouts....
February 18, 2022, 8:30 am
These 3 stocks just declared dividend raises
Big names in the food and beverage, industrial, and pharmaceutical sectors are lifting their payouts....
February 18, 2022, 8:30 am
Sanofi-regeneron's dupixent falls short in chronic spontaneous urticaria trial
Sanofi SA (NASDAQ: SNY) and Regeneron pharmaceuticals Inc (NASDAQ: REGN) have reported disappointin...
February 18, 2022, 7:11 am
Sanofi-regeneron's dupixent falls short in chronic spontaneous urticaria trial
Sanofi SA (NASDAQ: SNY) and Regeneron pharmaceuticals Inc (NASDAQ: REGN) have reported disappointin...
February 18, 2022, 7:11 am
Sanofi-regeneron's dupixent falls short in chronic spontaneous urticaria trial
Sanofi SA (NASDAQ: SNY) and Regeneron pharmaceuticals Inc (NASDAQ: REGN) have reported disappointin...
February 18, 2022, 7:11 am
Immunic, inc. to present preclinical data for vidofludimus calcium at the 17th congress of european crohn's and colitis organization and announces blinded baseline characteristics of its phase 2 caldo
NEW YORK, Feb. 18, 2022 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical...
February 18, 2022, 6:30 am
Immunic, inc. to present preclinical data for vidofludimus calcium at the 17th congress of european crohn's and colitis organization and announces blinded baseline characteristics of its phase 2 caldo
NEW YORK, Feb. 18, 2022 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical...
February 18, 2022, 6:30 am
Immunic, inc. to present preclinical data for vidofludimus calcium at the 17th congress of european crohn's and colitis organization and announces blinded baseline characteristics of its phase 2 caldo
NEW YORK, Feb. 18, 2022 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical...
February 18, 2022, 6:30 am
Fda approves agios' mitapivat as first disease-modifying therapy for genetic blood disorder
The FDA approved Agios pharmaceuticals Inc's (NASDAQ: AGIO) Pyrukynd (mitapivat) for hemolytic anemi...
February 18, 2022, 5:41 am
Fda approves agios' mitapivat as first disease-modifying therapy for genetic blood disorder
The FDA approved Agios pharmaceuticals Inc's (NASDAQ: AGIO) Pyrukynd (mitapivat) for hemolytic anemi...
February 18, 2022, 5:41 am
Fda approves agios' mitapivat as first disease-modifying therapy for genetic blood disorder
The FDA approved Agios pharmaceuticals Inc's (NASDAQ: AGIO) Pyrukynd (mitapivat) for hemolytic anemi...
February 18, 2022, 5:41 am
Ligand pharmaceuticals incorporated (lgnd) ceo john higgins on q4 2021 results - earnings call transcript
Ligand pharmaceuticals Incorporated (LGND) CEO John Higgins on Q4 2021 Results - Earnings Call Transcri...
February 17, 2022, 9:57 pm
Ligand pharmaceuticals incorporated (lgnd) ceo john higgins on q4 2021 results - earnings call transcript
Ligand pharmaceuticals Incorporated (LGND) CEO John Higgins on Q4 2021 Results - Earnings Call Transcri...
February 17, 2022, 9:57 pm
Ligand pharmaceuticals incorporated (lgnd) ceo john higgins on q4 2021 results - earnings call transcript
Ligand pharmaceuticals Incorporated (LGND) CEO John Higgins on Q4 2021 Results - Earnings Call Transcri...
February 17, 2022, 9:57 pm
Aerie pharmaceuticals to announce fourth quarter and full year 2021 financial results and host conference call on thursday, february 24, 2022 at 5:00 p.m. et
DURHAM, N.C.--(BUSINESS WIRE)--AERI 4Q & FY21 Save-the-Date...
February 17, 2022, 4:45 pm
Aerie pharmaceuticals to announce fourth quarter and full year 2021 financial results and host conference call on thursday, february 24, 2022 at 5:00 p.m. et
DURHAM, N.C.--(BUSINESS WIRE)--AERI 4Q & FY21 Save-the-Date...
February 17, 2022, 4:45 pm
Aerie pharmaceuticals to announce fourth quarter and full year 2021 financial results and host conference call on thursday, february 24, 2022 at 5:00 p.m. et
DURHAM, N.C.--(BUSINESS WIRE)--AERI 4Q & FY21 Save-the-Date...
February 17, 2022, 4:45 pm
West pharmaceutical services, inc. (wst) ceo eric green on q4 2021 results - earnings call transcript
West pharmaceutical Services, Inc. (WST) CEO Eric Green on Q4 2021 Results - Earnings Call Transcript...
February 17, 2022, 3:18 pm
West pharmaceutical services, inc. (wst) ceo eric green on q4 2021 results - earnings call transcript
West pharmaceutical Services, Inc. (WST) CEO Eric Green on Q4 2021 Results - Earnings Call Transcript...
February 17, 2022, 3:18 pm